Exciting pharmacokinetic methods for anticonvulsants Newsletter Article 17 February 2013 Pages: 3 - 3
Clinical trials of T-cell vaccinations against autoimmune diseases needed Newsletter Article 17 February 2013 Pages: 3 - 4
Beta blockers and diuretics still win out in hypertension Newsletter Article 17 February 2013 Pages: 4 - 4
Possible new class of anxiolytics with fewer side effects Newsletter Article 17 February 2013 Pages: 5 - 5
Duteplase study may explain lack of improved survival with alteplase Newsletter Article 17 February 2013 Pages: 6 - 6
Two novel beta agonists compare favourably with salbutamol Newsletter Article 17 February 2013 Pages: 6 - 6
ACE inhibitors in AMI: SMILE pilot justifies large-scale study Newsletter Article 17 February 2013 Pages: 8 - 8
Digoxin Fab fragments increase survival - at a price Newsletter Article 17 February 2013 Pages: 8 - 9
Mexiletine more cost-effective than quinidine and procainamide Newsletter Article 17 February 2013 Pages: 9 - 9
Restricting antibacterials leads to more appropriate use Newsletter Article 17 February 2013 Pages: 10 - 10
Increased mortality in CAST: did the antiarrhythmics have a selective effect? Newsletter Article 17 February 2013 Pages: 10 - 11
Ofloxacin - an alternative to oxytetracycline in NGU Newsletter Article 17 February 2013 Pages: 11 - 11
Empiric ceftazidime monotherapy is adequate: a meta-analysis Newsletter Article 17 February 2013 Pages: 12 - 12
Calcium antagonists improve long term renal transplant outcome Newsletter Article 17 February 2013 Pages: 13 - 13
Should imipramine be used in primary nocturnal enuresis? Newsletter Article 17 February 2013 Pages: 16 - 17
Ranitidine - no tolerance or rebound in patients with duodenal ulcer Newsletter Article 17 February 2013 Pages: 18 - 18
Susceptibility to antipsychotic-induced extrapyramidal effects in AIDS Newsletter Article 17 February 2013 Pages: 18 - 19